Cholecystolithiasis, Choledocholithiasis, Cholelithiasis, Gallstones
Conditions
Keywords
laparoscopic transcystic common bile duct exploration, laparoscopic common bile duct exploration, endoscopic sphincterotomy,, cost-effective analysis
Brief summary
Patients with gallstone and confirmed common bile duct stones are registered in this study. The three managements for common bile duct stones are endoscopic sphincterotomy (EST), laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative investigations, operative method, operative time, conversion to open procedure, intraoperative and postoperative complications, and the presence of retained and recurrent stones. All patients were followed up for 3 years by telephone interview ang outpatient visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom appeared during the follow-up period. If there were unusual findings, magnetic resonance cholangiopancreatography(MRCP) was carried out.
Interventions
Sphincterotomy (EST) is performed to remove the common bile duct stone.
Transductal exploration was carried out to remove the common bile duct stone. Primary closure or a T tube drainage was performed according to the results of transductal surgery.
A wide local dissection of Calot's triangle is performed and a 2.8mm, 3-mm or 5-mm flexible choledochoscope according to the diameter of the cystic duct is inserted through the cystic duct into the common bile duct. After the common bile duct stone is removed, the cystic duct was ligated with Hem-o-lok.
Laparoscopic cholecystectomy is performed to remove the gallbladder.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with age between 18 - 80 years. * Patients diagnosed with gallstones. * Patients diagnosed with common bile duct stone by one of the three exam (MRI、MRCP and CT). * Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration. * Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).
Exclusion criteria
* Combined with Mirizzi syndrome and intrahepatic bile duct stones * Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD) * History of upper abdominal surgery. * Serious heart,brain,lung, metabolic diseases history. * Pregnant women * Unwillingness or inability to consent for the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Adverse outcomes | 3 years | The patients with complication / the total patients |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospital stay | 3 years | The total days in hospital |
| Acute cholangitis rate | 30 days | The patients with acute cholangitis / the total patients |
| Bile leakage rate | 30 days | The patients with bile juice found in the abdominal cavity after procedures / the total patients |
| Stricture of the bile duct rate rate | 3 years | The patients with any stricture appeared after the procedures / the total patients |
| Incremental cost-effectiveness ratio | 3 years | the average incremental cost associated with 1 additional unit of the measure of effect |
| Perforation Rate | 30 days | The patients with perforation after the procedures / the total patients |
| Hemorrhage Rate | 3 years | The patients with hemorrhage after the procedures / the total patients |
| Operation time | 3 years | The total time of all the procedures (min) |
| Acute pancreatitis Rate | 30 days | The patients with acute pancreatitis after the procedures / the total patients |
| Mortality | 3 years | Number of death connected with the procedures and complications / total patients |
Countries
China